Results 111 to 120 of about 1,494 (190)

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II. [PDF]

Leukemia
Beird HC, Kannan S, Liu J, Chen J, Olguin A, Desai P, Cai T, Han L, Cotton JL, Singh S, Gupta SK, Little L, Estecio MR, Song X, Abbas HA, Zhang J, Gumbs C, Brooks C, Kantarjian H, Andreeff M, Konopleva M, Futreal PA, Pemmaraju N.   +22 more
europepmc   +1 more source

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report and review of the literature. [PDF]

Front Immunol
Yang F, Li D, Lei Y, Liu R, Fu Z, Ma L, Deng B, Ke X, Hu K.   +8 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): Morphological mimicry of lymphoid neoplasms. [PDF]

Br J Haematol
Guo H, Wei Y, Wang C, Guo X, Zhao G.
europepmc   +1 more source

Tagraxofusp in adult blastic plasmacytoid dendritic cell neoplasm: clinical trials and real-world outcomes: a systematic review. [PDF]

Front Immunol
Muthanna B, Manthiri AA, Haj Saleh L, Al-Mashdali AF, Mohamed SF.   +4 more
europepmc   +1 more source

Isolated central nervous system involvement in blastic plasmacytoid dendritic cell neoplasm: a rare case of relapse during systemic remission with diagnostic and therapeutic implications. [PDF]

Front Oncol
Zhao H, Huang W, Lin S, Chen Y.
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm With del(3)(p14p22): Diagnostic Pitfalls and an Uncommon Cytogenetic Finding in a Vietnamese Patient. [PDF]

J Cutan Pathol
Tran GH, Nguyen TT, Luong KA.
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm following Langerhans cell histiocytosis. [PDF]

JAAD Case Rep
Goto M, Akatsuka T, Uchiyama E, Urabe H, Shibamiya A, Nakaseko C, Komuta M, Hayashi Y, Hamada T, Sugaya M.   +9 more
europepmc   +1 more source

Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification. [PDF]

Curr Hematol Malig Rep
Loghavi S, Hasserjian RP.
europepmc   +1 more source

Diagnosis and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

Int J Dermatol
Gandarillas S, Mehregan D, Wolfe S, Dasgeb B.   +3 more
europepmc   +1 more source

Anticipating and overcoming resistance in blastic plasmacytoid dendritic cell neoplasm: new insights from pivekimab sunirine. [PDF]

Haematologica
Sapienza MR.
europepmc   +1 more source